GlaxoSmithKline Sells Rabies and Tick Vaccines in $1.1 Billion Deal

GALWAY, IRELAND--November 6, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) has struck a 955 million-euro ($1.1 billion) deal to sell its two travel vaccines to Denmark's Bavarian Nordic (Kvistgaard, Denmark). Within this article: Details vaccines sale, value of deal, GSK's vaccines division, new products and financial performance.